ERBB2 and breast cancer: Regarding patient prognosis, a high CD8 expression level was found to be an independent poor prognostic factor in all breast cancers and was associated with shorter DFS in luminal B, ER-positive, PR-negative, HER-2-positive, and high Ki-67 L.I. breast cancer.